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Abstract 
Background: Dietary patterns and their association with subsequent clinical course have not 
been well-studied in early MS. 
Objectives: To describe dietary patterns in people in five years following first clinical 
demyelination, and assess associations with MS conversion and relapse.  
Methods: Baseline food frequency questionnaire dietary intake (entry to the Ausimmune 
Study) and 5-year follow-up; iterated principal factor analysis applied. MS conversion and 
relapse risks assessed by Cox proportional hazards models, adjusted for age, sex, study site, 
education, BMI, smoking, and omega-3 supplement use.   
Results: In cases with a first clinical diagnosis of CNS demyelination, we identified three 
major dietary patterns, ‘Prudent, ‘High-Vegetable’, and ‘Mixed’, explaining 43%, 37% and 
24% of diet variance in dietary intake. Fruits, vegetables, fish, wholegrains and nuts loaded 
highly on the Prudent pattern, starchy vegetables and legumes on the High-Vegetable pattern, 
and meats and alcohol on the Mixed pattern. Diet factor scores were not associated with MS 
conversion risk. Those with baseline Prudent scores above the median had significantly lower 
relapse risk (adjusted hazard ratio=0.54, 95%CI 0.37-0.81) with some evidence of a plateau 
effect.   
Conclusions: Prudent diet factor score above the median prospectively associated with lower 
relapse risk in five years following first clinical demyelinating event.  
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Abbreviations 
BMI Body Mass Index 
CNS Central Nervous System 
CIS Clinically Isolated Syndrome 
FCD First Clinical Diagnosis of CNS demyelination 
FFQ Food Frequency Questionnaire 
HR Hazard ratio 
MS          Multiple sclerosis 
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Introduction 
While there has long been interest in the impacts of specific diets in multiple sclerosis (MS)1-
3, there have been few well-conducted studies with prospective collection of diet and disease 
progression measures. Due to the complexity of the human diet, and of its measurement, the 
study of diet is challenging. Traditional approaches to analyses of diet and MS in 
observational studies have focused on specific foods and nutrients4-6. However, dietary 
pattern analysis takes account of the whole diet and the effect of food combinations, to 
explore associations between certain eating styles and determinants of disease progression in 
people with MS7. While prior studies have explored a relationship with dietary pattern and 
MS risk8, associations with disease progression have not been reported.   
 
A better understanding of the determinants of diet factor scores could provide information for 
clinical management in this area. In addition, demonstrating prospective associations between 
patterns and clinical outcomes could guide dietary recommendations for people with MS and 
indicate points for intervention. The present study builds upon the work conducted in the 
Ausimmune Study8-11, which indicated a beneficial impact of healthy dietary intake in 
reducing the risk of MS onset, and to ascertain whether this effect is evident in relation to the 
disease course over five years of follow-up. The objectives of this study were to use a 
prospective cohort study to: 1) determine diet factor scores soon after first diagnosis of 
central nervous system (CNS) demyelination (baseline) using factor analysis; 2) investigate 
predictors of diet factor scores and change thereof between baseline and 5-year follow-up 
using diet data from baseline and 5-year reviews; and 3) test associations between diet factor 
scores and hazards of MS conversion and relapse.  
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Methods  
The Ausimmune Study was a population-based multicentre case-control study (2003-2006) 
conducted in four regions of eastern Australia: Brisbane, Newcastle and surrounds, Geelong 
and the Western Districts of Victoria, and Tasmania12.  The cohort comprised individuals 
presenting with a first clinical diagnosis of CNS demyelination including 1: clinically isolated 
syndrome (CIS); 2: first clinical diagnosis of CNS demyelination, but, on specific 
questioning, had a previous undiagnosed demyelinating event; 3: initial diagnosis of 
progressive-onset MS. Since 2009, the Ausimmune Longitudinal (AusLong) Study has 
investigated risk factors for early MS progression in cases from the Ausimmune Study13, with 
annual telephone data collection and face-to-face interviews at 2/3 years (retention=94.3%), 
and 5 years (retention=84.6%).   
 
Ethics committees of all participating centres approved both studies; all participants signed 
written informed consent. 
 
Food Frequency Questionnaire (FFQ) 
The self-administered Cancer Council Victoria Dietary Questionnaire for Epidemiological 
Studies version 2 assessed typical dietary intake for 101 foods and beverages over the 
previous year14. Nutrient intakes were estimated using Australian food composition data15.  
 
Clinical outcome measures 
First, analyses of diet factor scores were evaluated among all persons completing FFQs (at 
baseline with a first clinical diagnosis of CNS demyelination), to maximise generalisability to 
people with MS and to allow the application of diet factor scores to other outcomes in future 
studies. Then, the association between diet factor scores with MS conversion and relapse 
6 
 
included only CIS cases. This CIS only group was used to minimise any possible disease-
related influences on both choice of diet and the outcomes under study. 
 
Within-study and historical clinical history were derived from questionnaire and neurological 
notes. MS conversion was defined as the occurrence of a second clinical demyelinating 
episode (96.6%), or MRI evidence of a new lesion (3.4%)16. Relapses were defined according 
to the 2001 McDonald Criteria17; only diagnosed relapses were included in the analysis. All 
diagnosed relapses, including the first post-CIS relapse defining MS conversion and all 
subsequent events up to 5-year review, were included in relapse analyses.  
 
Other covariates 
Data were obtained from participants at face-to-face interviews as described previously18, 
including demographic characteristics, height and weight used to calculate BMI19, 
medication/supplement use (yes/no for vitamin D containing supplements, omega-3/6 
containing supplements, use of immunomodulatory medications), smoking 
(never/past/current), education, employment, and other characteristics. Physical activity was 
assessed using a modified version of the International Physical Activity Questionnaire20.  
 
Statistical methods 
Factor analysis 
FFQ items were grouped into 34 groups devised a priori (Supplemental Table 1)8, 21. We 
excluded participants with implausible energy intakes of <3000 or >20,000 kilojoules/day 
(n=15), as per prior research21, 22. Of note, application of a more stringent energy intake at 
bounds of the 25th percentile minus the interquartile range and the 75th percentile plus the 
interquartile range as described previously23 produced similar factors and factor loadings 
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(data not shown). Food intake data were adjusted for energy using the residual method24, 
whereby food groups were adjusted for energy intake and the residuals from this model 
defining the food groups used in the factor analyses. 
 
Iterated principal-factor analysis with oblique rotation7 was applied to the baseline food 
intake data to determine dietary factor scores, and these were used as predictors of MS 
conversion and relapse. In addition, iterated principal-factor analysis with oblique rotation 
was applied using dietary intake data from baseline and 5-year follow-up, estimating factor 
scores at each timepoint from a single model. Factor scores from this combined analysis were 
used to evaluate change in factor scores between the baseline and 5-year follow-up. The 
Bartlett test of sphericity was significant for both models (p<0.001), supporting sampling 
adequacy. Food groups having a factor loading ≥|0.20| were considered important 
contributors to each pattern. Individual participant diet factor scores at baseline and 5-year 
follow-up were predicted using the Bartlett method25. 
 
Statistical analysis 
Relationships of nutrient content with diet factor scores were assessed using univariable 
linear regression. Characteristics of baseline dietary pattern scores were investigated using 
linear regression, adjusted for age, sex, and study site. Predictors of changes in diet factor 
scores were investigated using linear regression, adjusting for age, sex, study site, and 
baseline dietary factor score. Further adjusted models included education, baseline BMI, 
baseline current smoking, and baseline use of omega-3/6-containing supplements. In 
addition, to allow comparability with the CIS-only clinical outcome analyses, characteristics 
of baseline diet factor scores and change thereof were evaluated constrained to CIS-only 
(Supplementary Tables 4 & 6).  
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Predictors of time to MS conversion and of relapse were evaluated by Cox proportional-
hazards regression, relapse models with shared frailties, estimating hazard ratios (HR) and 
adjusted hazard ratios (aHR). Diet factor scores were evaluated first as continuous terms, and 
then to examine potential threshold/plateau effects, diet factor scores were categorised into 
quartiles. MS conversion and relapse models were adjusted for age, sex, and study site, and 
further adjusted for baseline BMI, baseline smoking, and baseline omega-3/6 supplement use. 
Further adjustment for baseline physical activity and immunomodulatory medication use had 
no material impact (data not shown). Time-at-risk for MS conversion and relapse began from 
the referral episode date. All covariates satisfied the proportional hazards assumption except 
study site for relapse, so models were estimated including products terms of study site and 
time.  
 
For all analyses, p-values for tests for trend for ordinal polytomous variables were calculated 
by replacing the dummy dichotomous variables of the polytomous variable with a single 
variable, thus estimating the significance of the difference from 1 of a linear trendline across 
the levels of the polytomous variable. 
Statistical analyses were conducted in Stata/SE 15.1 (StataCorp LP, College Station, USA). 
Results 
Baseline and 5-year FFQs were completed by 96% of participants with a first clinical 
diagnosis of CNS demyelination (268/279, and 227/236, respectively; Table 1) and 209 
participants completed FFQs at both timepoints. Over half of the participants were 
overweight/obese and most had low physical activity. Baseline characteristics were generally 
similar for those with and without FFQ data. However, current smokers were significantly 
less likely to have completed an FFQ at both timepoints. Amongst eligible participants with a 
CIS only, 159/170 completed the baseline FFQ and 137/145 the 5-year follow-up FFQ; 128 
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CIS participants completed FFQs at both baseline and follow-up. Associations with 
covariates at baseline and predictors of change in score from baseline to 5-year follow-up for 
CIS were similar to those for the full participant group (with a first clinical diagnosis of CNS 
demyelination, Supplemental Tables 4 & 6). 
Characteristics of dietary patterns  
Three factors were identified (“Prudent”, “High-Vegetable”, and “Mixed”) using the 
baseline-only FFQ, which explained 43%, 37%, and 24% of the post-rotation variances 
(Table 2). Foods loading positively on the Prudent diet factor score included fresh fruit, non-
fried fish, nuts, and leafy vegetables. Foods loading positively on the High-Vegetable diet 
factor scores included yellow/red and cruciferous vegetables, legumes, potatoes, and sauce. 
Foods loading positively on the Mixed diet factor score included poultry, red and processed 
meat, and alcohol. Similar characteristics were seen at baseline for the combined (baseline 
and 5-year follow-up) factor analysis used for analyses of change in diet factor scores 
(Supplemental Table 2).  
 
The nutritional components of the diet substantiated the characterisations of the diet patterns, 
such that healthy nutrients were positively associated with Prudent and High-Vegetable and 
unhealthy with Mixed diet factor scores (Supplemental Table 3). The Prudent diet factor 
score was positively associated with omega-3, magnesium, potassium, iron and vitamins C 
and E, but negatively with total and saturated fats. High-Vegetable diet factor score was 
positively associated with magnesium, potassium, and vitamins C and E, but negatively with 
cholesterol. Mixed diet factor score was positively associated with protein, cholesterol, and 
zinc, but negatively with carbohydrates, sugars, and vitamin E.  
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Covariates associated with baseline diet factor scores  
As in Table 3, baseline Prudent diet factor score was significantly and independently higher 
among participants in the oldest age quartile, among the more physically active, those taking 
omega-3/6 supplements, and those who had completed university, but lower among 
overweight participants. Current smokers and those engaged in physical labour had lower 
Prudent diet factor scores, but these associations attenuated and became non-significant on 
adjustment. High-Vegetable diet factor score was significantly lower among current smokers 
and among those who had completed TAFE/trade school. Mixed diet factor score was 
significantly higher among ex and current smokers, and among those who had completed 
university but was lower among the non-employed. No diet factor scores were significantly 
and independently associated with age, sex, vitamin D supplement use, MS onset type, or 
immunomodulatory medication use. Results were not materially different on restricting to 
CIS cases (Supplemental Table 4). 
 
Change in diet factor scores (baseline to 5-year follow-up) and characteristics thereof 
There was little change in diet factor scores during follow-up, average Prudent diet factor 
score increasing only 0.02 and High-Vegetable 0.06, while Mixed decreased by 0.04 
(Supplemental Table 5). Those who were obese at baseline review showed a significantly 
greater increase in Prudent diet factor score. However, no other characteristics were 
significantly and robustly associated with subsequent change in diet factor scores. Results 
were not materially different on restricting to CIS cases (Supplemental Table 6).  
 
Diet and clinical outcomes 
MS conversion – No baseline diet factor scores were associated with MS conversion hazard, 
nor was there any consistent dose-dependency suggestive of trend (Table 4).  
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Relapse hazard – As a continuous term, a one-unit higher Prudent score showed an inverse 
trend, with a 13% lower hazard of relapse (p=0.11), persisting in magnitude on further 
adjustment (aHR=0.85, p=0.09). As a quartile categorical term this reached significance 
(ptrend=0.034), albeit of mixed dose-dependency, and consolidating the lower two levels 
showed evidence of a plateau effect, such that those in the top two levels had 52% and 40% 
lower relapse risk (ptrend=0.017) and those above the median score had 46% lower relapse risk 
relative to the bottom 50% (p=0.002, Figure 1). Neither High-Vegetable nor Mixed diet 
factor scores showed any associations with relapse risk.  
Discussion  
Diet is a modifiable lifestyle factor which people with MS may alter with the aim of 
improving their prognosis. In this prospective study of people with early MS, we provide 
evidence of three dietary patterns that we labelled, “Prudent, “High-Vegetable”, and 
“Mixed”. Foods loading strongly on each factor, their nutritional characteristics, and baseline 
characteristics of participants were generally in line with the labels ascribed to each pattern. 
Over the 5-year follow-up, there was little change in diet factor scores. In participants with a 
CIS at baseline, no diet factor scores were significantly associated with subsequent risk of 
MS conversion. However, higher Prudent diet factor score was associated with reduced 
relapse risk, such that those above the median had a 46% lower relapse risk.   
Others have examined the association of dietary intake with MS and clinical progression4-6, 26, 
27, including using factor analysis or related methods8, 28.  The AusLong cohort has previously 
examined a range of factors for their associations with clinical progression in early MS, 
ranging from sun and vitamin D metabolite levels29, BMI and dyslipidaemia8, 28, tobacco and 
marijuana smoking8, and genetic risk factors2, 30. Also, the Ausimmune case-control study13 
from which the AusLong Study derives, has explored a range of lifestyle factors, including 
diet8-11, 26. Our results are in keeping with the previous Ausimmune findings that a healthy 
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diet8, particularly one rich in fish11, was inversely associated with case status. That our 
present study did not show a significant association between Prudent diet factor score and MS 
conversion risk contrasts with these results, although the focus of that analysis was a first 
clinical diagnosis of CNS demyelination, rather than MS conversion. Also, here these 
analyses were restricted to CIS cases. Moreover, whereas the Ausimmune analyses based 
their factor analysis on the healthy control population, leading to the estimation of two 
factors, one Healthy and one Western, our factor analysis used dietary intake from the cases 
and led to three generally healthy diets. Thus, while the healthiest diet pattern in this sample, 
which we labelled Prudent, was inversely associated with relapse risk, neither of the other 
two patterns was distinctly deleterious.  
The results seen for Prudent diet factor score and relapse are promising as they suggest a 
potential point of intervention whereby a better quality of diet may be beneficial in reducing 
clinical progression. Although we did not see a significant association of Prudent diet factor 
score with MS conversion risk, there was an inverse trend, albeit one of inconsistent dose-
dependency. The two outcomes in this sample are related – the MS conversion event is the 
first post-CIS relapse for the majority of the sample (where the diagnosis was based on a 
second clinical episode). Thus, we would hope for internal consistency that a true association 
would show a signal for both MS conversion and relapse, despite the lower event numbers for 
MS conversion which limits statistical power compared to relapse. However, as noted, the 
dietary behaviour of the whole cohort was generally healthy in nature, the worst being 
“Mixed” in character. It may be that the healthiest of these behaviours might have a long-
term accrued benefit against the inflammatory processes underlying both MS conversion and 
relapse but not one which as strongly protects against the initial diagnostic event.  
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Participants largely did not change their diet factor scores during follow-up diet factor score. 
Although those of obese BMI at baseline were significantly more likely to increase their 
Prudent diet factor score compared to normal BMI participants, no other characteristics were 
significantly associated with changes in diet factor scores. Using the case-control Ausimmune 
Study, Russell and colleagues examined determinants of change in dietary intake following a 
first clinical diagnosis of CNS demyelination (FCD)31, finding no significant demographic or 
behavioural determinants, which is in line with our results.   
 
Several advantages exist for analysing dietary intake as diet factor score, including taking 
account of whole diet, overcoming collinearity between nutrients, and decreasing the number 
of statistical tests needed to model disease hazard7. We acknowledge the limitation of FFQs 
in that some respondents underestimate intake. They are also subject to some recall error in 
contrast to more proximal 24-hour recall instruments. Nonetheless, FFQs remain one of the 
most practical dietary methods for epidemiological studies. While our sample size is 
somewhat small, this is balanced by a robust, prospective longitudinal study design, including 
the measurement of dietary intake in a consistent and systematic fashion at baseline and 
follow-up, and the thorough assessment of relapse and clinical activity, both by 
questionnaire, study neurological review, and review of neurological notes. A further 
limitation is that we assessed diet only at baseline and 5-year timepoints. It is possible that 
dietary changes through years 1-4 may have altered the risk of MS conversion or relapse, 
although our analyses show little change in diet from baseline to 5 years. Finally, those with 
more active disease may have had more motivation to change their diet in some fashion, and 
some medications like Tecfidera can impact on appetite, potentially leading to changes in 
diet. 
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The Ausimmune Study aimed to recruit all eligible cases within the study regions13, and there 
was high participation amongst eligible cases32. The AusLong Study had excellent retention 
at 5 years. Thus, the cohort is representative of the cases who had a first clinical diagnosis of 
CNS demyelination between 2003 and 2006 from the study regions, supporting the 
generalisability of these findings. Importantly, in recruiting a sample soon after referral for a 
clinically isolated syndrome potential behaviour change secondary to disease is unlikely.  
In conclusion, we have reproducibly shown three dietary patterns, a healthy Prudent, and two 
other patterns, one High-Vegetable and the other Mixed, which characterised the dietary 
intake of the cohort over five years of follow-up. These patterns are substantiated by their 
food group components, their agreement with nutritional and behavioural characteristics, and 
are comparable to those recently described using the baseline portion of this cohort8. We 
found that high baseline Prudent diet factor score was associated with a subsequent lower 
relapse risk, but not associated with MS conversion risk. Given the great public interest in 
diet and its potential role in MS onset and progression, its modifiable nature, as well as 
biological plausibility for the role of diet in MS, further investigation of the impact of diet on 
MS clinical course is warranted. 
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Figure 1. Kaplan-Meier plot of baseline Prudent diet score (above vs below median) vs subsequent hazard of relapse. Note: 100% survival 
indicates the whole cohort being relapse-free, which only occurs at baseline.  
  
